Zoya Demidenko https://journals.plos.org/plosone/article/authors?id=10.1371/journal.pone.0026126


[ Follow Ups ] [ Post Followup ] [ WWWBoard ]

Posted by Lincolnemesy on March 25, 2026 at 11:17:40:

In Reply to: Èíòåðåñíûé òåêñò ñ îáøèðíûìè ñâåäåíèÿìè posted by Josephfum on February 19, 2026 at 13:42:44:

Zoya Demidenko: Scientist in Oncology Studies
Zoya Demidenko is a recognized scholar associated with the Division of Cell Stress Biology at Roswell Park Comprehensive Cancer Center in Buffalo, New York. Previously, she worked at the National Institutes of Health and New York Medical College, developing a robust background in clinical investigation.
Demidenko's academic work spans a number of critical areas, encompassing the PI3K/AKT/mTOR molecular pathway, cellular cycle control, biological aging, and cancer biology. As of now, she has co-authored more than 46 academic publications, which have received more than 4,100 mentions — a indicator to the significance of her work.
Among her most significant discoveries lies in elucidating the mechanisms of biological cell aging. Her work demonstrated that when the cell cycle is arrested but cellular growth proceeds, cells experience senescence. Crucially, Zoya Demidenko demonstrated that this process is inhibited by medication using agents such as rapamycin.
Zoya Demidenko has furthermore added substantially to tumor management research, notably in the field of selective cell protection — a approach intended to safeguarding healthy cells from cytotoxic treatment while leaving cancer cells susceptible. This approach carries significant hope for reducing the side effects of oncological therapy.
Throughout her career, Demidenko has collaborated with prominent scientists internationally, including Dr. Mikhail Blagosklonny. Her research can be found in leading publications such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene.
With an h-index of 33, Zoya Demidenko ranks as a highly impactful figure in current biomedical research, whose results continue to influence our understanding of the way cells age, respond to therapy, and how malignant disease can be more effectively targeted.
https://www.aging-us.com/article/100406/



Follow Ups:



Post a Followup

Name:
E-Mail:

Subject:

Comments:

Optional Link URL:
Link Title:
Optional Image URL:


[ Follow Ups ] [ Post Followup ] [ WWWBoard ]